Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Amrapali Industries Limited (AMRAPLIN.BO)

17.77
-1.02
(-5.43%)
At close: April 22 at 3:24:52 PM GMT+5:30
Loading Chart for AMRAPLIN.BO
  • Previous Close 18.79
  • Open 17.15
  • Bid 17.77 x --
  • Ask 18.50 x --
  • Day's Range 17.01 - 18.89
  • 52 Week Range 14.50 - 20.24
  • Volume 38,487
  • Avg. Volume 8,939
  • Market Cap (intraday) 913.566M
  • Beta (5Y Monthly) -0.57
  • PE Ratio (TTM) 111.06
  • EPS (TTM) 0.16
  • Earnings Date May 28, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Amrapali Industries Limited engages in the bullion and share trading business in India. The company trades in precious metals, such as gold and silver. It is also involved in the entertainment recreational activities. Amrapali Industries Limited was incorporated in 1988 and is based in Ahmedabad, India.

www.amrapalispot.com

29

Full Time Employees

March 31

Fiscal Year Ends

Recent News: AMRAPLIN.BO

View More

Performance Overview: AMRAPLIN.BO

Trailing total returns as of 4/22/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

AMRAPLIN.BO
2.90%
S&P BSE SENSEX (^BSESN)
1.86%

1-Year Return

AMRAPLIN.BO
0.89%
S&P BSE SENSEX (^BSESN)
8.07%

3-Year Return

AMRAPLIN.BO
0.89%
S&P BSE SENSEX (^BSESN)
39.16%

5-Year Return

AMRAPLIN.BO
0.89%
S&P BSE SENSEX (^BSESN)
153.65%

Compare To: AMRAPLIN.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMRAPLIN.BO

View More

Valuation Measures

Annual
As of 4/21/2025
  • Market Cap

    966.00M

  • Enterprise Value

    1.65B

  • Trailing P/E

    117.44

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.00

  • Price/Book (mrq)

    3.04

  • Enterprise Value/Revenue

    0.01

  • Enterprise Value/EBITDA

    19.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    275.75B

  • Net Income Avi to Common (ttm)

    8.88M

  • Diluted EPS (ttm)

    0.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.66M

  • Total Debt/Equity (mrq)

    224.11%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: AMRAPLIN.BO

View More

Company Insights: AMRAPLIN.BO

Research Reports: AMRAPLIN.BO

View More

People Also Watch